Macrogenics Overview
Macrogenics Target Price
Analysts' 12-month price predictions for MGNX.
Get informed when a big investor buys or sells
+ FollowShare Price
$4.29
Average Target Price
$6.00
39.9% upside
39.9% upside1 analysts in the last 4 months
High: $6 | Low: $6
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-04-20 | Barclays | $6 | 39.9% upside |  |
| 2025-05-14 | BarclaysPeter Lawson | $3 |  30.1% downside | |
| 2025-03-25 | H.C. Wainwright | $2 | 53.4% downside | |
| 2024-08-07 | Stifel NicolausStephen Willey | $6 | 39.9% upside | |
| 2024-07-31 | JMP SecuritiesSilvan Tuerkcan | $8 | 86.5% upside | |
| 2024-07-31 | B.Riley FinancialMayank Mamtani | $5 | 16.6% upside | |
| 2024-07-29 | BarclaysPeter Lawson | $9 | 109.8% upside | |
| 2024-05-23 | BTIGKaveri Pohlman | $9 | 109.8% upside | |
| 2024-05-13 | H.C. WainwrightDebjit Chattopadhyay | $4 | 6.8% downside | |
| 2024-05-10 | BarclaysPeter Lawson | $14 | 226.3% upside | |
| 2024-05-10 | BMO CapitalEtzer Darout | $8 | 86.5% upside | |
| 2024-04-04 | Stifel NicolausStephen Willey | $29 | 576% upside | |
| 2022-11-22 | GuggenheimCharles Zhu | $12 | 179.7% upside | |
| 2022-07-11 | BTIGKaveri Pohlman | $6 | 39.9% upside | |
| 2021-06-16 | WedbushDavid Nierengarten | $32 | 645.9% upside | |